- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
4
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
4 companies
BioStem Technologies
Market Cap: US$187.4m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$10.70
7D
-10.6%
1Y
36.3%
Puma Biotechnology
Market Cap: US$162.8m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.29
7D
1.5%
1Y
-13.3%
SIGA Technologies
Market Cap: US$427.2m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$5.98
7D
1.2%
1Y
-21.1%
Black Diamond Therapeutics
Market Cap: US$125.1m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$2.37
7D
17.9%
1Y
-49.9%